NCT05918159 is a clinical trial of Sarcopenia Assessment in Sarcopenia, sponsored by Universidade do Algarve.

Who is sponsoring NCT05918159?

NCT05918159 is sponsored by Universidade do Algarve.

What drugs are being tested in NCT05918159?

Interventions in NCT05918159: Sarcopenia Assessment.

What condition does NCT05918159 study?

NCT05918159 studies Sarcopenia, Sarcopenic Obesity, Frailty.

Is NCT05918159 still recruiting?

NCT05918159 is currently completed. Last updated 14 August 2023.

Last reviewed 2023-08-14 · How we verify

NCT05918159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Sarcopenia on General Health Status in Elderly: a Population-based Study

Completed Last updated 14 August 2023

What this trial tests

trial testing Sarcopenia Assessment in Sarcopenia in 274 participants. Completed in 20 February 2023.

Timeline

14 May 2019

Primary endpoint
20 February 2023

20 February 2023

Quick facts

Lead sponsor	Universidade do Algarve
Status	Completed
Study type	OBSERVATIONAL
Enrollment	274
Start date	14 May 2019
Primary completion	20 February 2023
Estimated completion	20 February 2023
Sites	1 location across Portugal

Drugs / interventions tested

Sarcopenia Assessment

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Sarcopenic Obesity — all drugs for Sarcopenic Obesity →
Frailty — all drugs for Frailty →

Sponsor

Universidade do Algarve

Who can join

60 and older, any sex, with Sarcopenia or Sarcopenic Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a observational study, that aimed to determine the prevalence of sarcopenia using European Wording Group on Sarcopenia in Older People (EWGSOP) algorithm in a general elderly population in Algarve region (Portugal). Because muscle is metabolically active tissue, sarcopenia may also contribute to the development of some of the metabolic disorders associated with aging. However, the risk factors associated with sarcopenia are poorly understood. Thus, a cross-sectional survey of a sample of 274 elderly adults aged 60 or over, were included in the study. Correlations of sarcopenia with functional level, lipid and glycemic profile, nutritional and physical activity level, fall risk, quality of life, and self-reported comorbidities will be studied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sarcopenia Assessment

Trials testing the same drug.

NCT05015114 — Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome · completed

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Universidade do Algarve trials

Trials by the same sponsor.

NCT07268274 — Metabolic Trajectories and Protein Intake in Long-Stay Ventilated Intensive Care Unit (ICU) Patients · active not recruiting
NCT04605900 — Impact of Therapeutic Footwear and Plantar Orthoses on Diabetic Neuropathic Foot in Quality of Life and Functionality · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05918159 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade do Algarve
Last refreshed: 14 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05918159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing